J Korean Soc Neonatol.
2006 Nov;13(2):261-266.
Treatment of Congenital Chylothorax in a Premature Infant using Octreotide
- Affiliations
-
- 1Department of Pediatrics, College of Medicine, Soonchunhyang University, Bucheon and Seoul Hospital, Korea. kimss@schbc.ac.kr
Abstract
- Chylothorax, defined as escape of chyle from the thoracic duct into the thoracic cavity, is the most common cause of pleural effusion during the neonatal period. The use of octreotide, a synthetic analogue of the somatostatin, for the treatment of congenital idiopathic chylothorax, has not been previously reported in Korea. We report here a case of idiopathic congenital chylothrax successfully treated with octreotide in a premature infant who showed no response to conservative therapies.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Serious Necrotizing Enterocolitis in a Neonate Treated with Octreotide for Congenital Chylothorax
- Povidone-Iodine Pleurodesis for Chylothorax in an Extremely Low Birth Weight Infant
- A clinical study of congenital chylothorax and octreotide therapy
- Two cases of postoperative chylothorax treated with parenteral octreotide and conservative therapy
- A Case of Congenital Chylothorax in a Premature Infant
